Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay Lichter currently holds 7,682 shares of ARATANA THERAPEUTICS, INC. (PETX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay Lichter has been a net seller of PETX stock. They have purchased $26.4M and sold $105.2M worth of shares.
Jay Lichter's most recent insider trade was on Sep 13, 2024, when they sold 391 shares at $0.00 per share.
Jay Lichter serves as Executive at ARATANA THERAPEUTICS, INC. (PETX). They have executed 52 insider transactions totaling $131.7M over their tenure at the company.
Jay Lichter holds the position of Executive at ARATANA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Jay Lichter has shown a selling trading pattern, with $26.4M in total purchases and $105.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jay Lichter was on Jan 23, 2020, when they sold $114.4M worth of THOR shares. This transaction involved 1,682,086 shares at $68.00 per share.
Jay Lichter currently owns 7,682 shares of ARATANA THERAPEUTICS, INC. (PETX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay Lichter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay Lichter has 52 Form 4 filings on record as an insider at ARATANA THERAPEUTICS, INC..
Set alerts for Jay Lichter and 40,000+ other insiders.